hero-logo-doclabel
graphic-icon-product

A comprehensive labeling intelligence solution that enables rapid prior precedent research, automated comparisons and competitive monitoring to inform product strategy and development.

Deployed by the top pharma companies, DocLabel™ lets the user compare drug labels across the US, UK, EU and Canada and provides real-time updates.

doclabel-screenshot

DATA SOURCES

  • US package inserts
  • Canadian product monographs
  • UK summaries of product characteristics
  • EU summaries of product characteristics
  • Local country uploads
  • Proprietary core data sheet across label comparison

UNLOCK NEW POSSIBILITIES IN
EFFICIENCY ACROSS FUNCTIONAL AREAS

icon-product-assets-document-01

Research & Development

Research & Development teams can develop more differentiated clinical trial design through comprehensive and intuitive searches for specific outcomes.

icon-product-assets-bottle-4-01

Regulatory Affairs

Regulatory Affairs teams can drive commercial success by leveraging comprehensive labeling intelligence to review prior precedent, compare and annotate labels and continuously monitor areas of interest. DocLabel allows your teams to spend more time on strategic activities as well as respond more rapidly to requests from healthcare authorities during label negotiations.

icon-doctorAsset 2

Medical Affairs

Medical Affairs teams can gather real-time intelligence and support product strategy.

icon-safetyAsset 5

PV/Epi/Safety

PV/Epi/Safety teams can more readily ensure patient safety.  Automated monitoring of adverse events and real-time surveillance of competitor labels can not only identify class effects or potential signals, but also accelerate your response time to safety-related regulatory requests.

icon-bulbAsset 2@2x

Commercial

Commercial teams can leverage labeling intelligence to better understand competitive landscape and drive commercial and product development strategies.